Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1107 | 979 | 1236 | 1124 | 1379 | - |
Fund Return | 10.74% | -2.1% | 23.65% | 3.97% | 6.64% | - |
Place in category | 320 | 1192 | 201 | 824 | 806 | - |
% in Category | 13 | 57 | 9 | 46 | 53 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IGlobal Franchise Fund A EUR Acc | 8.5B | 6.14 | 2.39 | 9.68 | ||
Investec Glbl Strat EM EqI Acc EUR | 1.65B | 15.35 | 0.40 | 4.64 | ||
Invec GlblStrat GlblStratEqA AccEUR | 1.44B | 18.36 | 4.49 | 8.70 | ||
Invec GlblStratGlblStratEqS Inc EUR | 1.44B | 20.17 | 6.33 | 10.64 | ||
Investec GlblStrat Euro EqI Acc EUR | 480.37M | 10.68 | 3.97 | 6.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 156.18M | 12.55 | 4.13 | 5.59 | ||
European Growth Fund E Acc EUR | 20.48M | 11.84 | 3.35 | 4.80 | ||
European Growth Fund Y Acc EUR | 169.03M | 13.30 | 5.02 | 6.46 | ||
European Growth Fund Y DIST EUR | 63.37M | 13.33 | 5.02 | 6.47 | ||
European Growth Fund A DIST Eue | 6.45B | 12.54 | 4.13 | 5.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.76 | 750.9 | -0.67% | |
ASML Holding | NL0010273215 | 5.54 | 669.40 | +6.64% | |
SAP | DE0007164600 | 4.98 | 219.930 | +0.22% | |
Barclays | GB0031348658 | 3.11 | 256.75 | -0.81% | |
AstraZeneca | GB0009895292 | 3.07 | 10,242.0 | +0.97% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review